The long-term value of the selected list as a method of controlling drug costs in a district general hospital.
The results of a study aimed at evaluating the long-term effects of the Limited List (now officially referred to as the Selected List Scheme) on inpatient drug costs in a district general hospital (DGH) are presented. Study periods of six months duration were examined before, shortly after, and a further year after implementation of the List on 1 April 1985. Eight therapeutic classes affected by the regulations were examined; in four of these (antacids, expectorants, mucolytics and anxiolytics, hypnotics and sedatives) statistically significant reductions in costs were demonstrated over the study periods. There was no significant change in the costs of the other four classes (vitamins, laxatives, nasal preparations and analgesics). Overall, inpatient expenditure for the hospital showed no significant change. The changes in cost demonstrated can be attributed to the Selected List and occurred despite the prior existence of a local formulary.
D003363:Cost Control / Q000379:methods*; D003365:Costs and Cost Analysis / Q000706:statistics & numerical data; D004739:England; D005069:Evaluation Studies as Topic; D005572:Formularies, Hospital as Topic / Q000191:economics*; D013222:State Medicine